Clinical research progress in the breast cancer therapy-related hematological neoplasms / 肿瘤

ABSTRACT

Breast cancer is one of the most frequent cancers among females. With the diversification of early diagnosis and treatment methods, the survival time of breast cancer patients is obviously prolonged. However, based on the huge population of breast cancer and a longer period of survival, the complication, especially the hematological malignancies, resulted from the breast cancer treatment Chave raised attention of the public. The purpose of this review focuses on the pathogenesis, mechanism and prognosis of breast cancer therapy-related hematological neoplasms, so as to improve the understanding of therapy-related hematological neoplasms.